Profile
APLM VRTX REGN ALNY SGEN ARGX
Company Name Apollomics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $7.22M $117.98B $57.12B $43.28B $43.15B $33.34B
Employees 0.01K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Guo-Liang Yu Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
APLM VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 2
Quant Rating Sell Sell Buy Strong Sell Neutral Sell
Trading
APLM VRTX REGN ALNY SGEN ARGX
Last Close $6.54 $466.36 $547.75 $317.5 $228.74 $538.64
High 52 $11.53 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $0.09 $396.64 $482.92 $224.58 $228.74 $457.68
Price vs. 52 Week High -43.28 % -9.75 % -54.42 % -4.34 % 0 % -19.82 %
Price vs. 52 Week Low 7166.67 % 17.58 % 13.42 % 41.38 % 0 % 17.69 %
Total Return
APLM VRTX REGN ALNY SGEN ARGX
1 Month Return -1.65 % 4.53 % 5.78 % 4.44 % 0 % -7.71 %
3 Month Return 15.1 % -3.3 % -4.93 % 30.53 % 0 % -4.47 %
6 Month Return -36.75 % 13.16 % -25.33 % 31.99 % 0 % -17.04 %
9 Month Return 4740.86 % -0.34 % -45.88 % 17.2 % 0 % 3.48 %
YTD Return -32.92 % 15.81 % -23.1 % 34.93 % 0 % -12.42 %
1 Year Return 3302.71 % -4.04 % -48.03 % 24.64 % 0 % 17.69 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APLM VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.33 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1058.08 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
APLM VRTX REGN ALNY SGEN ARGX
Asset Growth -76.35 % -0.87 % 36.55 %
Gross Profit Growth -100 % 10.25 % 77.08 %
Revenue Growth -100 % 11.66 % 78.6 %
Revenue 3 Year -100 % 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth 69.02 % -93.69 % 128.87 %
Net Income Growth 68.8 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 46.77 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share -9.91 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -9.91 % 33.84 % 938.02 %
Operating Income Growth 22.8 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) 33.48 % -113.93 % 80.31 %
Operating 3 Year CFG 37.83 % -118.65 % 88.36 %
Operating 5 Year CFG -22.72 % -131.3 % -135.21 %
Operating 10 Year CFG -22.72 % 12.43 % -64 %
EPS Growth -2175.86 % -114.8 % 369.77 %
EPS Diluted Growth -2175.86 % -114.97 % 347.67 %
Book Value Per Share -90.53 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share 102.14 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 107.5 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 107.5 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -79.27 % 116.42 % 95.27 %
Free Cash Flow Growth 33.43 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
APLM VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 100 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -352.42 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -210.5 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -685.69 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 118.12 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -1859.51 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -2628.78 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM 16.55 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM - 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 206.23 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 16.04 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -27.41 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -27.44 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 1054.1 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -1208.37 % -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.09 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -2628.78 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.28 -93.78 18.91 -574.08 -81.26 -431.71
Price To Operating Cash Flows Ratio TTM -0.24 -120.39 14.52 -954.11 -93.1 -512.95
Price Cash Flow Ratio TTM -0.24 -120.39 14.52 -954.11 -93.1 -512.95
Income Statement (TTM)
APLM VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.05B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.05B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -52.8 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
APLM VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.01B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
APLM VRTX REGN ALNY SGEN ARGX
Net Income $-0.05B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.49
AARD Aardvark Therapeutics, Inc. Common Stock 12.74
ABCL AbCellera Biologics Inc. 4.225
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.83
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.245
ABPWW 0.02
ABSI Absci Corporation 2.83
ABUS Arbutus Biopharma Corporation 3.325
ABVC ABVC BioPharma, Inc. 4.685
ABVX Abivax SA American Depositary Shares 8.26
ACAD ACADIA Pharmaceuticals Inc. 21.545
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7114
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.365
ACIU AC Immune SA 2.07
Unlock